— Integrating Advanced eHealth Solutions with the Latest Telecommunications Services
VANCOUVER, British Columbia, October 02, 2024 — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc,” or the “Company”), an innovator in the eHealth sector, is pleased to announce its participation in the HLTH 2024 conference as part of the booth of one of the largest S&P 500 US-based telecommunications companies (“TelCo”).
Key Takeaways:
- UniDoc Health is showcasing its advanced eHealth platform at HLTH 2024 as part of TelCo’s booth.
- The partnership with TelCo integrates cutting-edge communication services with UniDoc’s healthcare offerings.
- Attendees can pre-book meetings with UniDoc representatives to explore the new solutions.
UniDoc CEO Antonio Baldassarre commented, “This collaboration with TelCo represents a tremendous opportunity for UniDoc to expand its reach and enhance the value of our eHealth platform. By working to integrate our eHealth solutions with TelCo’s global network, we are positioning ourselves to deliver innovative healthcare experiences and outcomes. Our participation in HLTH 2024 provides a platform to demonstrate how this partnership can benefit patients and providers alike.”
Running from October 20 to 23, 2024 at the Venetian Expo Center, Las Vegas, this event marks a first step in the ongoing partnership between UniDoc and TelCo, which is focused on integrating TelCo’s communication services with UniDoc’s eHealth platform to deliver comprehensive healthcare solutions to a global audience.
The partnership between UniDoc and TelCo aims to innovate patient engagement and clinician effectiveness through a combination of eHealth services and advanced communication platforms. Additionally, by leveraging AI-enhanced technologies, the collaboration seeks to improve data analysis, enabling more precise and predictive healthcare, leading to faster diagnosis and treatment options.
At HLTH 2024, UniDoc will showcase its innovative solutions designed to transform healthcare delivery. Attendees are encouraged to visit the UniDoc in the TelCo’s booth to learn more about how UniDoc’s eHealth platform, integrated with TelCo’s communication services, can address the evolving needs of the global healthcare community.
Interested attendees who wish to pre-book an in-person meeting with a Company representative are invited to email info@unidoctor.com indicating available times and dates along with reply contact information. All attempts will be made to accommodate your interest subject to availability.
UniDoc invites all to visit its website to learn more about our eHealth solutions and to watch our introductory video.
On Behalf of the Board of Directors,
~Antonio Baldassarre~
Antonio Baldassarre
CEO, President & Director
UniDoc Health Corp.
About UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF)
UniDoc is developing an eHealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician’s office. eHealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company’s belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at www.unidoctor.com and signup to receive the latest information with updates on our activities, events and progress.
For further information, please contact:
UniDoc Investor Relations
Tel: +1 778.383.6731
Email: info@unidoctor.com
Matt Chatterton, Director
Tel: +1 778.613.2082
Email: matt@unidoctor.com
Media Inquiries media@unidoctor.com
Forward-Looking Statements
This news release contains statements and information that, to the extent that they are not historical fact, may constitute “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as “may”, “would”, “could”, “will”, “will be”, “likely”, “except”, “anticipate”, “believe”, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook”, or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the Company’s attendance at HLTH 2024, participation with TelCo at HLTH 2024, the future partnership opportunities with TelCo, and the ability of the Company’s products to address the evolving needs of the global healthcare community.
Forward-looking information is based on the assumptions, estimates, analysis, and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; the Company’s ability to secure additional financing on reasonable terms; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company.
Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all; as well as all of the other risks as described in the Company’s annual management discussion and analysis dated July 31, 2024 under the heading “Risks Factors.” Accordingly, readers should not place undue reliance on any such forward-looking information.
Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.
The CSE does not accept responsibility for the adequacy or accuracy of this release.